Background
INVEGA TRINZA, a 3-month injection, is an atypical antipsychotic
indicated for the treatment of Schizophrenia in patients after they have been adequately treated with INVEGA SUSTENNA. Developed by Janssen Pharmaceuticals (Johnson & Johnson).
Invega Trinza was a break through in the area of Schizophrenia treatment and it became our main focus. However, instead of focusing on medical charts, we pushed for a lifestyle approach that provided insights on how you can pursue life when you are on treatment.
UX Discovery
- Business Requirements
- Competitive Research
- Content Audit of Invega Brands
- Franchise Model Approach
- SEO Research
- Analytics research to understand current user journey
- User Personas
- User Flows
UX Define
- Ideation and whiteboarding
- Hi-Fi Omnigraffle wireframes
- Mid-Fi Axure wireframes (View Prototype)
Creative / Development
Worked with internal creative and client off shore development team to ensure requirements are met and efficient delivery on final product.